ANTRIN PA PILOT

ANTRIN PA PILOT

ANTRIN Photo-Angioplasty for Prevention of Peripheral Restenosis–PILOT. A study evaluating the safety and efficacy of a photosensitizer, motexafin (Antrin), in the endovascular treatment of atherosclerosis.
Conclusion Motexafin is safe, well-tolerated and may help limit atherosclerosis.